• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘Serious and growing threat’

by December 9, 2024
written by December 9, 2024

Pro-life leaders are sounding off about the ‘serious and growing threat’ of chemical abortion pills after President-elect Trump said he would not restrict access to the pills as president.

Abortion pills, also known as chemical abortion, are now the most common abortion method, accounting for over 60% of all U.S. abortions.

During an interview with NBC’s ‘Meet the Press’ this past weekend, Trump was asked whether he would restrict abortion pill access via executive action.

Trump responded definitively that ‘the answer is no.’

He added: ‘I’ll probably stay with exactly what I’ve been saying for the last two years,’ that abortion is a state, not a federal issue.

Pressed whether he would commit to not restricting abortion pills, the president-elect said: ‘Well I commit’ but noted circumstances may change.

‘Do things change? I think they change,’ he went on, pointing to how President Biden pardoned his son Hunter Biden after repeatedly categorically committing otherwise. 

‘I don’t like putting myself in a position like that,’ he said. ‘So, things do change, but I don’t think it’s going to change at all.’

Chemical abortion access was significantly expanded under the Biden administration, which permanently removed a requirement for the pills to be administered through in-person appointments and allowed the drugs to be delivered via mail or obtained at retail pharmacies like CVS or Walgreens.

In a statement sent to Fox News Digital, Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, said ‘unregulated, mail-order abortion drugs are a serious and growing threat to women’s health and safety, as well as the lives of countless unborn children, all across this country.’

While she criticized the ‘reckless actions’ of the Biden-Harris administration to expand abortion pill access, Dannenfelser said ‘no one who cares about the health and well-being of women can afford to ignore this issue.’ 

Referring to the recent high-profile deaths of Catherine Herring, Amber Thurman, Candi Miller and Alyona Dixon due to abortion pill complications, Dannenfelser said ‘even the pro-abortion media can’t hide that these drugs are killing women and fueling dangerous new forms of domestic violence.’

Kristan Hawkins, president of Students for Life Action, indicated she was optimistic about Trump seeing the danger of unrestricted chemical abortion access, telling Fox News Digital: ‘Many leaders are just now learning about how the pills harm women and the environment.’  

‘We have a lot to talk about with the Trump-Vance administration,’ Hawkins said, adding, ‘President Trump has shown himself to be a reasonable leader who makes decisions based on the best information available.’

‘We hope to be agents of change, providing new information about how the changes made by the Biden-Harris administration on chemical abortion pill policy expose women to injury, infertility, and death, empowers abusers and allows for drinking water pollution through the flushing of medical waste,’ she said. ‘So, we look forward to a frank discussion about what three Democratic Party presidents did to help their friends in Big Abortion Pharma. We can’t wait to give President Trump the new information he needs to act.’ 

Meanwhile, Brian Burch, president of the conservative activism group ‘CatholicVote,’ told Fox News Digital that Trump’s admission that ‘things do change,’ signals ‘he would be open to addressing the overwhelming body of evidence that shows how harmful these drugs are to women.’

‘Big Pharma has exploited far too many women for too long, and the abortion industry should not get a pass when it comes to drug protocols and evidence-based regulations,’ he said. ‘Given President Trump’s pro-life record, together with the personnel he has nominated to key positions, we remain hopeful the new administration will take a serious look at these drugs and act accordingly.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
TikTok says ban would cost U.S. small businesses and creators $1.3B in first month
next post
Here is who is vying for power in Syria after the fall of Bashar al-Assad

related articles

Trump considers legal action against Michael Wolff and...

February 1, 2026

Senate Republicans push for House GOP rebellion against...

February 1, 2026

Tax season scams surge as filing confusion grows

February 1, 2026

Israel, Egypt coordinate reopening of Rafah Crossing in...

February 1, 2026

Trump says Iran ‘seriously talking to us’ as...

February 1, 2026

Amber Rose defends Charlie Kirk’s widow against online...

February 1, 2026

House Democrats mutiny Schumer’s deal with White House,...

February 1, 2026

State Department issues security alert amid ‘heavy gunfire’...

February 1, 2026

Noem touts TSA success after thousands with terror...

February 1, 2026

Hundreds rally outside Iranian UN ambassador’s Fifth Avenue...

February 1, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • As Iran talks get underway, expert raises alarm over lack of plan to secure nuclear material

    June 20, 2025
  • Burgum grilled on environmental issues targeted by Trump during confirmation hearing: ‘Drill, baby, drill’

    January 16, 2025
  • Republicans react to Biden’s ‘No one is above the law’ post following Hunter pardon

    December 2, 2024
  • Iran’s top prosecutor criticizes Trump’s announcement that 800+ executions were halted: ‘Completely false’

    January 23, 2026
  • Latin America fractures over Trump’s Maduro capture as regional allies shift right

    January 6, 2026

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,746)
  • Investing (920)
  • Stock (969)

Latest Posts

  • SCOOP: House Republicans request ban on federally funded ‘transgender animal’ experiments in 2026 budget

    May 24, 2025
  • China’s missile surge puts every US base in the Pacific at risk — and the window to respond is closing

    December 14, 2025
  • EURUSD and GBPUSD: GBPUSD climbs to a new August high

    August 21, 2024

Recent Posts

  • Former high-level United Nations officials to launch ‘DOGE-UN’ to highlight agency inefficiencies

    December 1, 2024
  • DOJ releases Special Counsel Jack Smith’s report on investigation into Trump election interference case

    January 14, 2025
  • Trump administration targets Maduro’s inner circle, family in major narco-state crackdown

    December 19, 2025

Editor’s Pick

  • President-elect Trump taps slew of administration picks days before inauguration

    January 17, 2025
  • MORNING GLORY: Trump meets Putin amid an era done away with John Quincy Adams’ ‘abroad’

    August 12, 2025
  • Amazon to pay $2.5 billion to settle FTC allegations that it duped customers into enrolling in Prime

    September 27, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock